Vaccine
Chikungunya vaccine (live attenuated)
Brand names: Ixchiq
Adult dose
Dose: Single 0.5mL IM dose
Route: IM
Frequency: once
Clinical pearls
- MHRA caution in adults ≥65 — review benefit-risk before use
Contraindications
- Immunosuppression
- Pregnancy
- Severe hypersensitivity
Side effects
- Headache
- Fatigue
- Myalgia
- Fever
- Rare severe adverse events in older adults
Interactions
- Avoid concurrent live vaccines unless co-administered
- Immunosuppressants reduce response
Reference: BNF; UK Green Book; https://bnf.nice.org.uk/drugs/chikungunya-vaccine-live/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
Pathways
- Infective Endocarditis · ESC 2023 Infective Endocarditis Guidelines; NICE NG41
- Eczema Herpeticum · BAD; NICE CKS
- Suspected Bacterial Meningitis (Adult) · NICE NG240 (2024); NICE NG143 (paeds)
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021
- Returning Traveller — Fever · NaTHNaC; PHE; ESCMID 2018
- Malaria — Diagnosis & Management · PHE 2016; WHO 2023